Zymfentra 120 mg/mL injection Images
Generic Name: infliximab
This medication has been identified as Zymfentra 120 mg/mL injection. It is supplied by Celltrion USA.
Zymfentra is used in the treatment of Ulcerative Colitis; Crohn's Disease; Inflammatory Bowel Disease; Crohn's Disease, Maintenance; Ulcerative Colitis, Maintenance and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Zymfentra 120 mg/mL injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zymfentra
- Generic Name
- infliximab
- Strength
- 120 mg/mL injection
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celltrion USA
- National Drug Code (NDC)
- 72606-0025
More about Zymfentra (infliximab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Patient resources
Other brands
Remicade, Inflectra, Avsola, Renflexis, Ixifi
Professional resources
Other brands
Remicade, Inflectra, Avsola, Renflexis
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.